Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cells

BACKGROUND: Most patients with advanced Ewing's sarcoma (EWS) respond poorly to conventional chemotherapy, indicating the need for new treatment approaches. Epigenetic events, such as promoter hypermethylation and chromatin histone deacetylation, silence the expression of tumor suppressor genes...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurtubise, Annie, Bernstein, Mark L, Momparler, Richard L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600626/
https://www.ncbi.nlm.nih.gov/pubmed/19014694
http://dx.doi.org/10.1186/1475-2867-8-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600626/
https://www.ncbi.nlm.nih.gov/pubmed/19014694
http://dx.doi.org/10.1186/1475-2867-8-16

Ejemplares similares